Scientists Engineer Yeast With a Third Redox Cofactor to Power Precision Biotech
Researchers created an orthogonal NMN(H)-based redox system in yeast, decoupled from native metabolism, enabling cleaner biomanufacturing of compounds.
Summary
Researchers at UC Irvine engineered baker's yeast to use nicotinamide mononucleotide (NMN) as a third, independent redox cofactor alongside the cell's native NAD(P)H systems. By rewiring glycolysis and accumulating intracellular NMN+ to levels rivaling NAD+, they created an orthogonal biochemical circuit that operates without interfering with normal cellular metabolism. This platform selectively drove a key chemical reduction reaction while avoiding unwanted side reactions that plague conventional approaches. The achievement marks the first self-sustained, new-to-nature redox cofactor system demonstrated in a eukaryotic organism, with broad implications for biomanufacturing, synthetic biology, and potentially the production of longevity-relevant compounds like NMN itself.
Detailed Summary
Metabolic engineering of yeast for biomanufacturing is powerful but messy. When researchers introduce new biosynthetic pathways, those pathways compete with the cell's native chemistry for shared resources — especially the universal electron carriers NAD(P)H. Sorting out who gets electrons, and when, has historically required extensive, laborious genetic rewiring.
To solve this, scientists at UC Irvine established a parallel, orthogonal redox infrastructure in Saccharomyces cerevisiae built around nicotinamide mononucleotide (NMN), a molecule already well-known in longevity circles as an NAD+ precursor. Unlike NAD(P)H, NMN-dependent reactions can be limited to only the specific engineered steps a researcher defines, dramatically simplifying optimization.
The team first rewired glycolysis — the cell's primary sugar-burning pathway — to eliminate NAD(P)H generation from glucose, repurposing glucose as a dedicated electron source for NMNH reducing power instead. They then showed that this NMN-driven system could selectively reduce citral to citronellal (relevant fragrance and flavor compounds) without over-reducing them to unwanted alcohols, a problem that plagues reactions using native cofactors due to the many endogenous alcohol dehydrogenase enzymes present.
Critically, the team engineered yeast to accumulate intracellular NMN+ at approximately 2.9 mM — comparable to cellular NAD+ concentrations — creating the first truly self-sustained orthogonal redox cofactor system in any eukaryotic organism. This demonstrates that NMN(H) can function as a genuine third nicotinamide-based redox currency in living cells.
For longevity science, this work is notable on two fronts: it deepens mechanistic understanding of NMN biochemistry in living cells, and it creates a generalizable platform that could accelerate biomanufacturing of longevity compounds. Caveats include the early-stage nature of the work, conducted entirely in yeast, with unclear translation to mammalian systems.
Key Findings
- NMN(H) established as a functional third redox cofactor in yeast, orthogonal to native NAD(P)H metabolism.
- Intracellular NMN+ accumulated to ~2.9 mM, matching endogenous NAD+ concentrations in engineered yeast.
- Glycolysis rewired to redirect glucose electrons exclusively into the NMN(H) system, decoupling it from native metabolism.
- NMN-driven reduction of citral to citronellal achieved selectively, avoiding unwanted over-reduction to alcohols.
- First self-sustained, new-to-nature orthogonal redox cofactor system demonstrated in a eukaryotic organism.
Methodology
The study used genetic engineering of S. cerevisiae to rewire glycolysis and introduce NMN(H)-dependent enzyme pathways. Researchers measured intracellular NMN+ accumulation and validated orthogonal redox activity using citral-to-citronellal reduction as a model reaction in resting cells.
Study Limitations
All experiments were conducted in yeast; applicability to mammalian or human cells remains undemonstrated. The study is early-stage and focused on proof-of-concept reactions rather than scalable production yields. Only a single model reaction (citral reduction) was used to validate selective NMN(H) activity.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: